Explore the words cloud of the TRACY project. It provides you a very rough idea of what is the project "TRACY" about.
The following table provides information about the project.
AT-BIOTECH TRACEABILITY INFORMATION SYSTEMS SL
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
|Duration (year-month-day)||from 2016-12-01 to 2017-05-31|
Take a look of project's partnership.
|1||AT-BIOTECH TRACEABILITY INFORMATION SYSTEMS SL||ES (MALAGA)||coordinator||50˙000.00|
AT-Biotech is a well established Spanish SME that offers high quality RFID traceability solutions to its clients in the healthcare sector. We have already developed a system, Rhesus, that focuses in the blood donor-to-patient cycle. Rhesus significantly improves patient safety and blood quality, but also optimises the efficiency of all operational processes. At the time of writing this proposal, Rhesus has successfully identified ~35K blood donations, identified, stored and distributed ~235K blood components, and helped complete ~18K transfusions.
In just 3 years we have signed long-term contracts with main Spanish players, where we intend to reach 60% penetration in Spanish Blood Establishments (BEs) and 30% penetration in Spanish hospitals by 2021. We also have promising international business perspectives with the Red Cross in Germany, Austria and Switzerland. Next steps to take will be: 1. Internationalisation. 2. Production-upscaling and industrialisation.
TRACY, our innovative RFID-UHF traceability platform for human-derived products, is an evolution of our former Rhesus platform that will help us to up-scale our production and fully internationalise our business, while providing our customers: 1. Huge SAFETY improvement. We intend to achieve 75% safety improvement in the transfusion stage (blood products). 2. Huge PRODUCTIVITY and EFFICIENCY improvement. We intend to achieve 15% improvement in the production stage. 3. Huge QUALITY improvement. As a result of a thorough traceability and cold-chain control in the whole blood life’s cycle.
Within first 3-years of business, TRACY will let us consolidate in Spain, UK, Germany, Austria & Switzerland, as well as set up in business in Portugal, Italy & France, which will let us obtain ~12M euro cumulative revenues by 2021 (RoI3-years = ~3).
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TRACY" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TRACY" are provided by the European Opendata Portal: CORDIS opendata.
In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise SoftwareRead More
ScanVid - One-Click Integrated Access to Product-related Digital ContentRead More
SME LOYALISER: fostering SME retailers through LOYALty Integrated SERvicesRead More